The GHIT Fund announces a funding award opportunity for the development of new medicines, vaccines, or diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases.

The proposed collaboration project may include R&D activities from pre-clinical research (post-lead optimization) through licensure. More specifically, we seek to fund a portfolio of innovative collaboration projects, such as:

• Pre-clinical development (e.g., lead-optimization, in-vivo studies, formulation development, chemistry and process validation)
• Clinical development (e.g., Phase 1, Phase 2, Phase 3, manufacturing scale up)
• Activities to support licensure and WHO prequalification

Please visit "Apply for funding" to know more details.